Acta Pharmaceutica Sinica B,
Journal Year:
2024,
Volume and Issue:
15(1), P. 278 - 295
Published: Nov. 27, 2024
Intestinal
fibrosis
is
a
significant
clinical
challenge
in
inflammatory
bowel
diseases,
but
no
effective
anti-fibrotic
therapy
currently
available.
Glucagon
receptor
(GCGR)
and
glucagon-like
peptide
1
(GLP1R)
are
both
hormone
receptors
involved
energy
metabolism
of
epithelial
cells.
However,
their
role
intestinal
the
underlying
mechanisms
remain
largely
unexplored.
Herein
GCGR
GLP1R
were
found
to
be
reduced
stenotic
ileum
patients
with
Crohn's
disease
as
well
fibrotic
colon
mice
chronic
colitis.
The
downregulation
led
accumulation
metabolic
byproduct
lactate,
resulting
histone
H3K9
lactylation
exacerbated
through
epithelial-to-mesenchymal
transition
(EMT).
Dual
activating
by
1907B
cells
ameliorated
vivo.
We
uncovered
GCGR/GLP1R
regulating
EMT
via
lactylation.
Simultaneously
novel
dual
agonist
holds
promise
treatment
strategy
for
alleviating
fibrosis.
Cell Death and Disease,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 18, 2025
Abstract
Cardiovascular
diseases
are
the
leading
causes
of
death
worldwide.
However,
there
still
shortcomings
in
currently
employed
treatment
methods
for
these
diseases.
Therefore,
exploring
molecular
mechanisms
underlying
cardiovascular
is
an
important
avenue
developing
new
strategies.
Previous
studies
have
confirmed
that
metabolic
and
epigenetic
alterations
often
involved
across
patients.
Moreover,
factors
interact
with
each
other
affect
progression
a
coordinated
manner.
Lactylation
novel
posttranslational
modification
(PTM)
links
metabolism
epigenetics
affects
disease
progression.
analyzing
crosstalk
between
cellular
expected
to
provide
insights
development
The
purpose
this
review
describe
relationship
heart
such
as
failure,
myocardial
infarction,
atherosclerosis,
focus
on
acylation
methylation,
propose
potential
therapeutic
measures.
Frontiers in Genetics,
Journal Year:
2025,
Volume and Issue:
16
Published: April 3, 2025
The
existing
evidence
indicates
that
atherosclerosis
(AS)
plays
a
pivotal
role
in
the
progression
and
exacerbation
of
cardiovascular
diseases
their
associated
complications.
Current
diagnostic
therapeutic
strategies
for
are
limited
ability
to
facilitate
early
detection
personalized
treatment.
This
study
employs
systems
biology
approach
investigate
lactylation-related
genes
(LRGs)
pathogenesis
atherosclerosis,
while
considering
well-established
correlation
between
inflammatory
responses
development.
In
this
study,
we
utilized
datasets
obtained
from
Gene
Expression
Omnibus
(GEO)
as
well
data
previous
studies
on
(LRGs).
Following
this,
identified
17
lactylation
related
associate
with
(AS-LRGs)
GSE100927
dataset.
Subsequently,
employed
validation
dataset
(GSE43292)
assess
these
AS-LRGs,
resulting
identification
12
more
reliable
candidate
genes.
These
were
further
analyzed
functional
enrichment
through
Ontology
(GO)
annotation,
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
analysis,
gene
set
analysis
(GSEA).
To
elucidate
potential
utility
AS-LRGs
diagnosing
high-risk
plaques,
assessed
expression
both
late
stages
high-
low-risk
plaques.
We
then
constructed
interaction
networks
regulatory
relationships
among
LRGs,
miRNAs,
transcription
factors,
drugs.
Finally,
single
sample
Set
Enrichment
Analysis
(ssGSEA)
method
immune
infiltration
AS
evaluate
levels
cell
infiltration.
reliably
atherosclerosis:
five
upregulated
(LSP1,
IKZF1,
MNDA,
RCC2,
WAS)
seven
downregulated
(CSRP2,
PPP1CB,
CSRP1,
HEXIM1,
CALD1,
PDLIM1,
RANBP2).
elucidates
establishes
robust
foundation
future
research
into
targeted
therapies
clinical
applications
biomarkers.
BMC Biology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: April 6, 2025
Lactylation
is
a
newly
discovered
type
of
post-translational
modification,
primarily
occurring
on
lysine
(K)
residues
both
histones
and
non-histones
to
exert
diverse
effects
target
proteins.
Research
has
shown
that
lactylation
(Kla)
modification
ubiquitous
in
different
cells
participates
the
determination
cell
function
fate,
as
well
initiation
progression
various
diseases.
Precise
identification
Kla
sites
fundamental
for
elucidating
their
biological
functions
uncovering
application
potential.
Here,
we
proposed
novel
human
site
predictor
(named
PBertKla)
through
curating
reliable
benchmark
dataset
with
proper
sample
length
sequence
identity
threshold
train
protein
large
language
model
optimal
hyperparameters.
Extensive
experimental
results
consistently
demonstrated
our
possessed
robust
prediction
ability,
achieving
an
AUC
(area
under
receiver
operating
characteristic
curve)
value
over
0.880
independent
validation
data.
Feature
visualization
analysis
further
validated
effectiveness
feature
learning
representation
from
sequences.
Moreover,
benchmarked
PBertKla
against
other
cutting-edge
models
testing
sources,
highlighting
its
superiority
transferability.
All
indicated
excelled
automatic
sites,
it
would
advance
investigation
modifications
significance
health
disease.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(9), P. 1175 - 1175
Published: Sept. 19, 2024
Lactate,
an
important
metabolic
product,
provides
energy
to
neural
cells
during
depletion
or
high
demand
and
acts
as
a
signaling
molecule
in
the
central
nervous
system.
Recent
studies
revealed
that
lactate-mediated
protein
lactylation
regulates
gene
transcription
influences
cell
fate,
processes,
inflammation,
immune
responses.
This
review
comprehensively
examines
regulatory
roles
mechanisms
of
neurodevelopment,
neuropsychiatric
disorders,
brain
tumors,
cerebrovascular
diseases.
analysis
indicates
has
multifaceted
effects
on
system
function
pathology,
particularly
hypoxia-induced
damage.
Highlighting
its
potential
novel
therapeutic
target,
may
play
significant
role
treating
neurological
By
summarizing
current
findings,
this
aims
provide
insights
guide
future
research
clinical
strategies
for
disorders.
Acta Pharmaceutica Sinica B,
Journal Year:
2024,
Volume and Issue:
15(1), P. 278 - 295
Published: Nov. 27, 2024
Intestinal
fibrosis
is
a
significant
clinical
challenge
in
inflammatory
bowel
diseases,
but
no
effective
anti-fibrotic
therapy
currently
available.
Glucagon
receptor
(GCGR)
and
glucagon-like
peptide
1
(GLP1R)
are
both
hormone
receptors
involved
energy
metabolism
of
epithelial
cells.
However,
their
role
intestinal
the
underlying
mechanisms
remain
largely
unexplored.
Herein
GCGR
GLP1R
were
found
to
be
reduced
stenotic
ileum
patients
with
Crohn's
disease
as
well
fibrotic
colon
mice
chronic
colitis.
The
downregulation
led
accumulation
metabolic
byproduct
lactate,
resulting
histone
H3K9
lactylation
exacerbated
through
epithelial-to-mesenchymal
transition
(EMT).
Dual
activating
by
1907B
cells
ameliorated
vivo.
We
uncovered
GCGR/GLP1R
regulating
EMT
via
lactylation.
Simultaneously
novel
dual
agonist
holds
promise
treatment
strategy
for
alleviating
fibrosis.